BioNTech

IPO

Advancing science to transform cancer and infectious disease treatments

Public · Mainz, Germany · Founded 2008 · $1.2B raised

Headquarters
Mainz
Employees
5001–10000
Founded
2008
Business Model
B2B
Total Funding
$1.2B
Last Round
$325.0M Series BJul 2019
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

BioNTech is a global biotechnology company that develops medicines for cancer, infectious diseases, and other serious conditions. Its fully integrated approach combines immunology, translational drug discovery, clinical development, GMP manufacturing, and commercialization. The company applies a range of platforms, including mRNA, cell and gene therapies, antibodies, and small molecules.

Summary

BioNTech is a Biotech company based in Mainz, Germany, founded in 2008. It has raised $1.2B in total across 4 rounds, most recently a $325.0M Series B round in Jul 2019. Investors include Fidelity Management, MIG AG and European Investment Bank.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPODec 2020
$150.0M

Sign up to see all 6 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioNTech on Indexed.vc
<a href="https://indexed.vc/companies/biontech"><img src="https://indexed.vc/api/badge/company/biontech" alt="BioNTech on Indexed.vc" width="260" height="76" /></a>